Clinical Trial Contract Template for Australia

Generate a bespoke document

Trusted by 200k+ teams

4.7 Capterra
4.8 Product Hunt
4.6 Trustpilot

What is a Clinical Trial Contract?

The Clinical Trial Contract serves as the foundational legal document for conducting clinical research in Australia, establishing the rights, responsibilities, and obligations of all parties involved in a clinical trial. This contract type is essential for compliance with Australian regulatory requirements, including the Therapeutic Goods Act 1989, NHMRC guidelines, and state-specific health regulations. It is used when a pharmaceutical company, biotechnology company, or other sponsor wishes to conduct clinical research at an Australian institution, detailing everything from financial arrangements to data management protocols. The document must align with TGA requirements, ICH-GCP guidelines, and institutional policies while protecting the interests of all parties and trial participants. It typically includes comprehensive provisions for risk management, intellectual property rights, and publication procedures specific to the Australian research environment.

Reviewed by

Swetha Meenal

Legal Engineer, GenieAI

Swetha Meenal profile photo

A lawyer, legal researcher and legal tech founder, Swetha has built AI products deployed inside Tier 1 firms and enterprises. She ensures GenieAI's alignment with the latest regulation and executes testing on the legal robustness of Genie output.

Reviewed by

Imad Mohammed Nazar

Legal Engineer, GenieAI

Imad Mohammed Nazar profile photo

A Skadden-trained M&A lawyer, Imad advised on cross-border transactions and contractual risk before moving into legal AI. He reviews GenieAI's output for compliance and enforceability across our 150+ supported jurisdictions, as well as facilitating external benchmarking.

Jurisdiction

Australia

Publisher

GenieAI

Sector

Business

Cost

Free to use

Last updated

About the Clinical Trial Contract

A Clinical Trial Contract is the comprehensive legal agreement that governs clinical research activities in Australia. This document establishes the contractual relationship between pharmaceutical sponsors, research institutions, principal investigators, and other parties involved in conducting clinical trials. Under Australian law, these contracts must comply with strict regulatory requirements while protecting the rights of all parties and ensuring participant safety.

When do you need this document?

You need a Clinical Trial Contract whenever conducting clinical research in Australia involving investigational products. This includes Phase I through Phase IV trials for new pharmaceuticals, medical devices, or biologics. The contract is required before any trial activities commence and must be in place when a pharmaceutical company engages an Australian hospital or research institution to conduct clinical research. It's also necessary when establishing multi-site trials across different Australian states, as each site typically requires its own contract. Contract Research Organizations (CROs) managing trials on behalf of sponsors also need these agreements to define their scope of work and responsibilities.

Key legal considerations

Your Clinical Trial Contract must address several critical legal elements to ensure compliance and protect all parties. Financial provisions should clearly outline payment schedules, budget allocations, and cost responsibilities between sponsors and institutions. Indemnification clauses are crucial, typically requiring sponsors to indemnify institutions against claims arising from the investigational product while institutions maintain liability for their negligent acts. Intellectual property provisions must define ownership of trial data, publications rights, and any discoveries made during the research. Data management and privacy clauses must comply with the Privacy Act 1988, ensuring proper handling of participant health information. The contract should include detailed termination provisions, specifying circumstances for early trial cessation and procedures for data transfer and participant care.

Legal requirements in Australia

Australian Clinical Trial Contracts must comply with the Therapeutic Goods Act 1989 and TGA Clinical Trial Guidelines. All trials require approval from a Human Research Ethics Committee (HREC) meeting NHMRC standards, and the contract must reference this ethical approval. The agreement must incorporate ICH Good Clinical Practice (GCP) guidelines, which Australia has adopted as the standard for clinical trial conduct. State-specific health legislation may also apply depending on the trial location. The contract must include provisions for adverse event reporting to the TGA and ensure compliance with the Australian Clinical Trial Registry requirements. Insurance requirements must meet TGA specifications, typically requiring clinical trial insurance and professional indemnity coverage. The document should also address obligations under the National Statement on Ethical Conduct in Human Research 2007, particularly regarding participant consent processes and data confidentiality measures.

GOVERNING LAW

Applicable law

This Clinical Trial Contract is drafted to comply with Australia law. Key legislation includes:

Genie's Security Promise

Genie is the safest place to draft. Here's how we prioritise your privacy and security.

Your data is private:

We do not train on your data; Genie's AI improves independently

All data stored on Genie is private to your organisation

Your documents are protected:

Your documents are protected by ultra-secure 256-bit encryption

We are ISO27001 certified, so your data is secure

Organizational security:

You retain IP ownership of your documents and their information

You have full control over your data and who gets to see it